I wouldnt be standing here if the hospital staff hadnt acted so quickly, a grateful Eagle told Kennedy News
CEO Lee stated, D&D Pharmatech continues platform-based clinical expansion across two pillars: liver disease and CNS. He added, Histological results and additional biomarker data for DD01 will be released in the second quarter of this year. During the Q&A session after the presentation, a question was raised about DD01's strategic positioning, given that recently approved GLP-1 agonists for obesity treatment, such as Wegovy and Mounjaro, are now expanding into MASH indications
Hussein O, Alkhader A, Gohar A, Bhat A
Best for: Active patients and athletes who want peak physical performance, accelerated recovery, and noticeable changes in lean mass
Selenium Compounds as Novel Potential Anticancer Agents
Please speak with your provider to make sure you are selecting an MCO that they accept